• mail us help@24marketresearch.com
  • Int'l 1(332) 2424 294 (Int'l)

purchase customization

Leave This Empty:

choose chapter to purchase

table of content

1 Introduction to Research & Analysis Reports
1.1 Mice Model Technologies Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Mice Model Technologies Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Mice Model Technologies Overall Market Size
2.1 Global Mice Model Technologies Market Size: 2023 VS 2030
2.2 Global Mice Model Technologies Market Size, Prospects & Forecasts: 2023-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Key Mice Model Technologies Players in Global Market
3.2 Global Companies Mice Model Technologies Product & Technology
4 Mice Model Technologies Companies Profiles
4.1 BIOCYTOGEN
4.1.1 BIOCYTOGEN Company Summary
4.1.2 BIOCYTOGEN Business Overview
4.1.3 BIOCYTOGEN Mice Model Technologies Product Offerings & Technology
4.1.4 BIOCYTOGEN Mice Model Technologies R&D, and Plans
4.2 Charles River Laboratories
4.2.1 Charles River Laboratories Company Summary
4.2.2 Charles River Laboratories Business Overview
4.2.3 Charles River Laboratories Mice Model Technologies Product Offerings & Technology
4.2.4 Charles River Laboratories Mice Model Technologies R&D, and Plans
4.3 Cyagen Biosciences
4.3.1 Cyagen Biosciences Company Summary
4.3.2 Cyagen Biosciences Business Overview
4.3.3 Cyagen Biosciences Mice Model Technologies Product Offerings & Technology
4.3.4 Cyagen Biosciences Mice Model Technologies R&D, and Plans
4.4 Gempharmatech
4.4.1 Gempharmatech Company Summary
4.4.2 Gempharmatech Business Overview
4.4.3 Gempharmatech Mice Model Technologies Product Offerings & Technology
4.4.4 Gempharmatech Mice Model Technologies R&D, and Plans
4.5 genOway
4.5.1 genOway Company Summary
4.5.2 genOway Business Overview
4.5.3 genOway Mice Model Technologies Product Offerings & Technology
4.5.4 genOway Mice Model Technologies R&D, and Plans
4.6 ingenious targeting laboratory
4.6.1 ingenious targeting laboratory Company Summary
4.6.2 ingenious targeting laboratory Business Overview
4.6.3 ingenious targeting laboratory Mice Model Technologies Product Offerings & Technology
4.6.4 ingenious targeting laboratory Mice Model Technologies R&D, and Plans
4.7 Merck KGaA
4.7.1 Merck KGaA Company Summary
4.7.2 Merck KGaA Business Overview
4.7.3 Merck KGaA Mice Model Technologies Product Offerings & Technology
4.7.4 Merck KGaA Mice Model Technologies R&D, and Plans
4.8 Ozgene Pty Ltd.
4.8.1 Ozgene Pty Ltd. Company Summary
4.8.2 Ozgene Pty Ltd. Business Overview
4.8.3 Ozgene Pty Ltd. Mice Model Technologies Product Offerings & Technology
4.8.4 Ozgene Pty Ltd. Mice Model Technologies R&D, and Plans
4.9 Taconic Biosciences, Inc.
4.9.1 Taconic Biosciences, Inc. Company Summary
4.9.2 Taconic Biosciences, Inc. Business Overview
4.9.3 Taconic Biosciences, Inc. Mice Model Technologies Product Offerings & Technology
4.9.4 Taconic Biosciences, Inc. Mice Model Technologies R&D, and Plans
4.10 PolyGene AG
4.10.1 PolyGene AG Company Summary
4.10.2 PolyGene AG Business Overview
4.10.3 PolyGene AG Mice Model Technologies Product Offerings & Technology
4.10.4 PolyGene AG Mice Model Technologies R&D, and Plans
4.11 THE JACKSON LABORATORY
4.11.1 THE JACKSON LABORATORY Company Summary
4.11.2 THE JACKSON LABORATORY Business Overview
4.11.3 THE JACKSON LABORATORY Mice Model Technologies Product Offerings & Technology
4.11.4 THE JACKSON LABORATORY Mice Model Technologies R&D, and Plans
4.12 Yale School of Medicine
4.12.1 Yale School of Medicine Company Summary
4.12.2 Yale School of Medicine Business Overview
4.12.3 Yale School of Medicine Mice Model Technologies Product Offerings & Technology
4.12.4 Yale School of Medicine Mice Model Technologies R&D, and Plans
4.13 University of North Carolina
4.13.1 University of North Carolina Company Summary
4.13.2 University of North Carolina Business Overview
4.13.3 University of North Carolina Mice Model Technologies Product Offerings & Technology
4.13.4 University of North Carolina Mice Model Technologies R&D, and Plans
4.14 University of Nebraska Medical Center
4.14.1 University of Nebraska Medical Center Company Summary
4.14.2 University of Nebraska Medical Center Business Overview
4.14.3 University of Nebraska Medical Center Mice Model Technologies Product Offerings & Technology
4.14.4 University of Nebraska Medical Center Mice Model Technologies R&D, and Plans
4.15 Monash University
4.15.1 Monash University Company Summary
4.15.2 Monash University Business Overview
4.15.3 Monash University Mice Model Technologies Product Offerings & Technology
4.15.4 Monash University Mice Model Technologies R&D, and Plans
4.16 UMass Chan Medical School
4.16.1 UMass Chan Medical School Company Summary
4.16.2 UMass Chan Medical School Business Overview
4.16.3 UMass Chan Medical School Mice Model Technologies Product Offerings & Technology
4.16.4 UMass Chan Medical School Mice Model Technologies R&D, and Plans
4.17 University of Bonn
4.17.1 University of Bonn Company Summary
4.17.2 University of Bonn Business Overview
4.17.3 University of Bonn Mice Model Technologies Product Offerings & Technology
4.17.4 University of Bonn Mice Model Technologies R&D, and Plans
4.18 Columbia University
4.18.1 Columbia University Company Summary
4.18.2 Columbia University Business Overview
4.18.3 Columbia University Mice Model Technologies Product Offerings & Technology
4.18.4 Columbia University Mice Model Technologies R&D, and Plans
4.19 The University of Arizona
4.19.1 The University of Arizona Company Summary
4.19.2 The University of Arizona Business Overview
4.19.3 The University of Arizona Mice Model Technologies Product Offerings & Technology
4.19.4 The University of Arizona Mice Model Technologies R&D, and Plans
5 Sights by Region
5.1 By Region - Global Mice Model Technologies Market Size, 2024 & 2030
5.2 By Region - Global Mice Model Technologies Revenue, (2024-2030)
5.3 United States
5.3.1 Key Players of Mice Model Technologies in United States
5.3.2 United States Mice Model Technologies Development Current Situation and Forecast
5.4 Europe
5.4.1 Key Players of Mice Model Technologies in Europe
5.4.2 Europe Mice Model Technologies Development Current Situation and Forecast
5.5 China
5.5.1 Key Players of Mice Model Technologies in China
5.5.2 China Mice Model Technologies Development Current Situation and Forecast
5.6 Rest of World
6 Sights by Product
6.1 By Type - Global Mice Model Technologies Market Size Markets, 2024 & 2030
6.2 CRISPR Knockout
6.3 CRISPR Knockin
6.4 Random Insertions
6.5 ES Cell Modification (Homologous Recombination)
6.6 Others
7 Sights by Application
7.1 By Application - Global Mice Model Technologies Market Size, 2024 & 2030
7.2 Pharmaceutical Companies
7.3 Biotechnology Companies
7.4 Academic and Research Facilities
7.5 Contract Research and Manufacturing Organizations
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer